[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621237":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":53,"collaborators":55,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":65,"sex":71,"minAge":72,"maxAge":18,"enrollmentInfo":73,"targetDuration":18,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":86,"overallStatus":95,"whyStopped":18,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Nantes University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Palliative care protocol","EXPERIMENTAL","Protocol for life-support withdrawal and palliative care during the withdrawal process",[13],"Other: Protocol for palliative care and life-support withdrawal",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care","NO_INTERVENTION","Withdrawal of life support at the end of life will be performed according to the usual practices of the participating ICUs",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"Protocol for palliative care and life-support withdrawal","In the intervention group, end-of-life care will be provided in accordance with the study protocol, which specifies pharmacological management, nursing care, management of life-sustaining organ support, procedures for the assessment of comfort and pain, and support for relatives. Medical and nursing staff in intervention centers will receive on-site, face-to-face training on the care protocol within each ICU. An instructional video detailing the protocol will also be available.",[9],[25],{"name":26,"affiliation":5,"role":27},"Amélie SEGUIN, MD","PRINCIPAL_INVESTIGATOR",[29,34],{"name":26,"role":30,"phone":31,"phoneExt":32,"email":33},"CONTACT","02 53 48 22 40","+332","amelie.seguin@chu-nantes.fr",{"name":35,"role":30,"phone":18,"phoneExt":18,"email":36},"Jean REIGNIER, MD Professor","jean.reignier@chu-nantes.fr",[38],{"facility":39,"status":18,"city":40,"state":18,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"CHU Nantes","Nantes","44","France","FR",{"type":45,"coordinates":46},"Point",[47,48],-1.55336,47.21725,{"lat":48,"lon":47},[51],{"name":26,"role":30,"phone":52,"phoneExt":32,"email":33},"0253482240",{"type":54,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[56,58,61],{"name":57,"class":6},"University of Burgundy",{"name":59,"class":60},"Centre Hospitalier Universitaire de Saint Louis APHP","UNKNOWN",{"name":62,"class":6},"University Hospital, Tours","100621237","end-of-life-care-in-mechanically-ventilated-patients-impact-of-a-comprehensive-palliative-care-protocol-in-the-intensive-care-setting-100621237",false,"NCT07368010","End-of-life Care in Mechanically Ventilated Patients: Impact of a Comprehensive Palliative Care Protocol in the Intensive Care Setting","End-of-life Care in Mechanically Ventilated Patients: Impact of a Comprehensive Training to Palliative Care in the Intensive Care Setting. A Multicenter Cluster Randomised Trial","ARREVE-3","Inclusion Criteria:\n\n* Patient:\n\n  * Age ≥ 18 years\n  * ICU admission for more than 48 hours\n  * Receiving invasive mechanical ventilation\n  * A documented decision to withdraw life-sustaining therapies, made through a multidisciplinary collegial process and communicated to the designated surrogate decision-maker, family, or relatives\n  * At least one visit from a relative prior to the decision to withdraw life-sustaining therapies\n  * Provision of informed consent for study participation, or, if the patient lacks decision-making capacity, consent obtained from a relative or legally authorized representative\n* Relative:\n\n  * Age ≥ 18 years\n  * Has received at least one medical update regarding the patient's clinical status from an ICU physician prior to the decision to withdraw life-sustaining therapies\n  * Has provided informed consent for study participation\n\nExclusion Criteria:\n\n* Patient:\n\n  * Presence of a tracheostomy\n  * Brain death or involvement in an organ donation procedure\n  * Absence of any visit from a relative\n  * Subject to legal guardianship or other legal protection measures\n  * Incarcerated patient\n  * Participation in another interventional research study focused on end-of-life care\n  * Pregnant or breastfeeding woman\n* Relative:\n\n  * Inability to understand or speak French\n  * Subject to legal guardianship or other legal protection measures","ALL","18 Years",{"count":74,"type":75},720,"ESTIMATED","INTERVENTIONAL",[78],"NA","The ARREVE-3 trial will evaluate whether a structured palliative care protocol can improve end-of-life management for mechanically ventilated ICU patients in whom a decision to withdraw life-sustaining therapies has been made. This cluster-randomized controlled trial compares protocol-based care with usual practice across participating centers. The intervention includes comprehensive guidance on symptom management, sedation, nursing care, withdrawal procedures, and family support, supported by standardized staff training. The primary endpoint is adherence to recommended end-of-life practices, while secondary outcomes assess patient comfort, communication with relatives, and the impact on families and healthcare professionals",[81,82,83,84,85],"Palliative Care","Withdrawal of Life Support","Intensive Care Medicine","Sedation","Dying Process",[87,88,89,90,91,92,93,94],"End of life","intensive care medicine","mechanical ventilation","organ support","withdrawal","life support","sedation","palliative care","NOT_YET_RECRUITING","2026-01-20",{"date":98,"type":99},"2026-01-26","ACTUAL",{"date":101,"type":75},"2026-01-10",{"date":103,"type":75},"2029-01-10",{"name":5,"class":6},1]